210 related articles for article (PubMed ID: 19667120)
1. Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.
O'Boyle G; Mellor P; Kirby JA; Ali S
FASEB J; 2009 Nov; 23(11):3906-16. PubMed ID: 19667120
[TBL] [Abstract][Full Text] [Related]
2. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation.
Ali S; Robertson H; Wain JH; Isaacs JD; Malik G; Kirby JA
J Immunol; 2005 Jul; 175(2):1257-66. PubMed ID: 16002730
[TBL] [Abstract][Full Text] [Related]
3. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.
Gouwy M; Struyf S; Noppen S; Schutyser E; Springael JY; Parmentier M; Proost P; Van Damme J
Mol Pharmacol; 2008 Aug; 74(2):485-95. PubMed ID: 18469140
[TBL] [Abstract][Full Text] [Related]
4. The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins.
Rueda P; Balabanian K; Lagane B; Staropoli I; Chow K; Levoye A; Laguri C; Sadir R; Delaunay T; Izquierdo E; Pablos JL; Lendinez E; Caruz A; Franco D; Baleux F; Lortat-Jacob H; Arenzana-Seisdedos F
PLoS One; 2008 Jul; 3(7):e2543. PubMed ID: 18648536
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4.
Connell BJ; Sadir R; Baleux F; Laguri C; Kleman JP; Luo L; Arenzana-Seisdedos F; Lortat-Jacob H
Sci Signal; 2016 Nov; 9(452):ra107. PubMed ID: 27803285
[TBL] [Abstract][Full Text] [Related]
6. Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity in vitro and abrogates intra-articular lymphocyte recruitment in vivo.
Janssens R; Mortier A; Boff D; Vanheule V; Gouwy M; Franck C; Larsen O; Rosenkilde MM; Van Damme J; Amaral FA; Teixeira MM; Struyf S; Proost P
Oncotarget; 2016 Sep; 7(38):62439-62459. PubMed ID: 27566567
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulphate as a regulator of leukocyte recruitment in inflammation.
Kumar AV; Katakam SK; Urbanowitz AK; Gotte M
Curr Protein Pept Sci; 2015; 16(1):77-86. PubMed ID: 25692849
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration.
Ali S; Fritchley SJ; Chaffey BT; Kirby JA
Glycobiology; 2002 Sep; 12(9):535-43. PubMed ID: 12213786
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
[TBL] [Abstract][Full Text] [Related]
10. Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4.
Struyf S; Noppen S; Loos T; Mortier A; Gouwy M; Verbeke H; Huskens D; Luangsay S; Parmentier M; Geboes K; Schols D; Van Damme J; Proost P
J Immunol; 2009 Jan; 182(1):666-74. PubMed ID: 19109200
[TBL] [Abstract][Full Text] [Related]
11. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes.
Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P
Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746
[TBL] [Abstract][Full Text] [Related]
12. Galphas-coupled receptor signaling actively down-regulates alpha4beta1-integrin affinity: a possible mechanism for cell de-adhesion.
Chigaev A; Waller A; Amit O; Sklar LA
BMC Immunol; 2008 Jun; 9():26. PubMed ID: 18534032
[TBL] [Abstract][Full Text] [Related]
13. Integrin/Chemokine receptor interactions in the pathogenesis of experimental autoimmune encephalomyelitis.
Banisadr G; Schwartz SR; Podojil JR; Piccinini LA; Lanker S; Miller SD; Miller RJ
J Neuroimmune Pharmacol; 2014 Jun; 9(3):438-45. PubMed ID: 24477403
[TBL] [Abstract][Full Text] [Related]
14. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
Inngjerdingen M; Rolstad B; Ryan JC
J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between CXCR4/stromal derived factor-1 and VLA-4/VCAM-1 pathways regulates neutrophil retention in the bone marrow.
Petty JM; Lenox CC; Weiss DJ; Poynter ME; Suratt BT
J Immunol; 2009 Jan; 182(1):604-12. PubMed ID: 19109194
[TBL] [Abstract][Full Text] [Related]
16. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine.
Amara A; Lorthioir O; Valenzuela A; Magerus A; Thelen M; Montes M; Virelizier JL; Delepierre M; Baleux F; Lortat-Jacob H; Arenzana-Seisdedos F
J Biol Chem; 1999 Aug; 274(34):23916-25. PubMed ID: 10446158
[TBL] [Abstract][Full Text] [Related]
17. Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions: EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE.
Rajasekaran D; Gröning S; Schmitz C; Zierow S; Drucker N; Bakou M; Kohl K; Mertens A; Lue H; Weber C; Xiao A; Luker G; Kapurniotu A; Lolis E; Bernhagen J
J Biol Chem; 2016 Jul; 291(30):15881-95. PubMed ID: 27226569
[TBL] [Abstract][Full Text] [Related]
18. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy.
Mousavi A
Immunol Lett; 2020 Jan; 217():91-115. PubMed ID: 31747563
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 and vascular cell adhesion molecule 1 are key chemokine/adhesion receptors in the migration of cytokine-activated T cells.
Bryant J; Ahern DJ; Brennan FM
Arthritis Rheum; 2012 Jul; 64(7):2137-46. PubMed ID: 22275188
[TBL] [Abstract][Full Text] [Related]
20. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis.
Pablos JL; Santiago B; Galindo M; Torres C; Brehmer MT; Blanco FJ; García-Lázaro FJ
J Immunol; 2003 Feb; 170(4):2147-52. PubMed ID: 12574387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
